Aigen Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Aigen Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,213	Closed	-$324K	–	1077
2023 Q4	$324K	Buy	+5,213	New	+$292K	0.06%	462
2023 Q3	–	Sell	-26,959	Closed	-$1.36M	–	1133
2023 Q2	$1.36M	Buy	+26,959	New	+$1.43M	0.2%	140
2023 Q1	–	Sell	-11,711	Closed	-$732K	–	869
2022 Q4	$732K	Buy	11,711 +8,100	+224%	+$538K	0.1%	204
2022 Q3	$254K	Buy	+3,611	New	+$249K	0.04%	448
2021 Q4	–	Sell	-3,524	Closed	-$229K	–	1211
2021 Q3	$229K	Buy	+3,524	New	+$241K	0.04%	396
2020 Q2	–	Sell	-512	Closed	-$13K	–	1367
2020 Q1	$13K	Buy	+512	New	+$15.2K	﹤0.01%	1135

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Aigen Investment Management's AXNX Position: Q1 2024 in Review

Aigen Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 5,213 shares — an estimated $324K sold.

Aigen Investment Management first reported a position in AXNX in Q1 2020 and held it in 6 quarters. The position peaked at $1.36M in Q2 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

Aigen Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Aigen Investment Management sold 5,213 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $324K.
Aigen Investment Management first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
Aigen Investment Management's Axonics, Inc. Common Stock position peaked at $1.36M in Q2 2023.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.